Abstract
The advances in recombinant DNA technology which have occurred in the past two decades have led to the increasing use of genetically engineered micro-organisms (GEMs) in the production of a variety of therapeutic and industrially important products such as human insulin, interferons and growth hormones.1 Other examples which involve use of GEMs in practical applications include the development of recombinant vaccines,2 of ice– bacteria to reduce frost damage to crops3 and microbial and virus insecticides.4,5 The use of genetically engineered bacteria constructed to degrade specific recalcitrant pollutants has also been suggested.6,7
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
